Table of Content

1 Market Overview of Genomic Cancer Testing
1.1 Genomic Cancer Testing Market Overview
1.1.1 Genomic Cancer Testing Product Scope
1.1.2 Genomic Cancer Testing Market Status and Outlook
1.2 Global Genomic Cancer Testing Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Genomic Cancer Testing Market Size by Region (2018-2033)
1.4 Global Genomic Cancer Testing Historic Market Size by Region (2018-2023)
1.5 Global Genomic Cancer Testing Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Genomic Cancer Testing Market Size (2018-2033)
1.6.1 North America Genomic Cancer Testing Market Size (2018-2033)
1.6.2 Europe Genomic Cancer Testing Market Size (2018-2033)
1.6.3 Asia-Pacific Genomic Cancer Testing Market Size (2018-2033)
1.6.4 Latin America Genomic Cancer Testing Market Size (2018-2033)
1.6.5 Middle East & Africa Genomic Cancer Testing Market Size (2018-2033)
2 Genomic Cancer Testing Market by Type
2.1 Introduction
2.1.1 Fluorescence In Situ Hybridization
2.1.2 Polymerase Chain Reaction
2.1.3 Microarray Technology
2.1.4 Serum Proteomics
2.1.5 Nucleic Acid Sequencing
2.2 Global Genomic Cancer Testing Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Genomic Cancer Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic Cancer Testing Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Genomic Cancer Testing Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Genomic Cancer Testing Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Genomic Cancer Testing Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Genomic Cancer Testing Revenue Breakdown by Type (2018-2033)
3 Genomic Cancer Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Speciality Clinics
3.1.3 Research Institutes
3.1.4 Diagnostics Laboratories
3.1.5 Biopharmaceutical Companies
3.2 Global Genomic Cancer Testing Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Genomic Cancer Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic Cancer Testing Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Genomic Cancer Testing Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Genomic Cancer Testing Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Genomic Cancer Testing Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Genomic Cancer Testing Revenue Breakdown by Application (2018-2033)
4 Genomic Cancer Testing Competition Analysis by Players
4.1 Global Genomic Cancer Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
4.3 Date of Key Players Enter into Genomic Cancer Testing Market
4.4 Global Top Players Genomic Cancer Testing Headquarters and Area Served
4.5 Key Players Genomic Cancer Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic Cancer Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Devyser
5.1.1 Devyser Profile
5.1.2 Devyser Main Business
5.1.3 Devyser Genomic Cancer Testing Products, Services and Solutions
5.1.4 Devyser Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Devyser Recent Developments
5.2 Agendia
5.2.1 Agendia Profile
5.2.2 Agendia Main Business
5.2.3 Agendia Genomic Cancer Testing Products, Services and Solutions
5.2.4 Agendia Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Agendia Recent Developments
5.3 Illumina
5.3.1 Illumina Profile
5.3.2 Illumina Main Business
5.3.3 Illumina Genomic Cancer Testing Products, Services and Solutions
5.3.4 Illumina Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Personal Genome Diagnostics Recent Developments
5.4 Personal Genome Diagnostics
5.4.1 Personal Genome Diagnostics Profile
5.4.2 Personal Genome Diagnostics Main Business
5.4.3 Personal Genome Diagnostics Genomic Cancer Testing Products, Services and Solutions
5.4.4 Personal Genome Diagnostics Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Personal Genome Diagnostics Recent Developments
5.5 Veracyte
5.5.1 Veracyte Profile
5.5.2 Veracyte Main Business
5.5.3 Veracyte Genomic Cancer Testing Products, Services and Solutions
5.5.4 Veracyte Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Veracyte Recent Developments
5.6 Pacific Biosciences of California
5.6.1 Pacific Biosciences of California Profile
5.6.2 Pacific Biosciences of California Main Business
5.6.3 Pacific Biosciences of California Genomic Cancer Testing Products, Services and Solutions
5.6.4 Pacific Biosciences of California Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Pacific Biosciences of California Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen Genomic Cancer Testing Products, Services and Solutions
5.7.4 Qiagen Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Genomic Cancer Testing Products, Services and Solutions
5.8.4 Agilent Technologies Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Agilent Technologies Recent Developments
5.9 Natera
5.9.1 Natera Profile
5.9.2 Natera Main Business
5.9.3 Natera Genomic Cancer Testing Products, Services and Solutions
5.9.4 Natera Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Natera Recent Developments
5.10 Bio Rad Laboratories
5.10.1 Bio Rad Laboratories Profile
5.10.2 Bio Rad Laboratories Main Business
5.10.3 Bio Rad Laboratories Genomic Cancer Testing Products, Services and Solutions
5.10.4 Bio Rad Laboratories Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio Rad Laboratories Recent Developments
5.11 Myriad Genetics
5.11.1 Myriad Genetics Profile
5.11.2 Myriad Genetics Main Business
5.11.3 Myriad Genetics Genomic Cancer Testing Products, Services and Solutions
5.11.4 Myriad Genetics Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Myriad Genetics Recent Developments
6 North America
6.1 North America Genomic Cancer Testing Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Genomic Cancer Testing Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic Cancer Testing Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic Cancer Testing Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic Cancer Testing Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic Cancer Testing Market Dynamics
11.1 Genomic Cancer Testing Industry Trends
11.2 Genomic Cancer Testing Market Drivers
11.3 Genomic Cancer Testing Market Challenges
11.4 Genomic Cancer Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Genomic Cancer Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Genomic Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Genomic Cancer Testing Market Size Share by Region (2018-2023)
Table 4. Global Genomic Cancer Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Genomic Cancer Testing Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Genomic Cancer Testing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Genomic Cancer Testing Revenue Market Share by Type (2018-2023)
Table 9. Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Genomic Cancer Testing Revenue Market Share by Type (2024-2033)
Table 11. North America Genomic Cancer Testing Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Genomic Cancer Testing Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Genomic Cancer Testing Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Genomic Cancer Testing Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Genomic Cancer Testing Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Genomic Cancer Testing Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Genomic Cancer Testing Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Genomic Cancer Testing Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Genomic Cancer Testing Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Genomic Cancer Testing Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Genomic Cancer Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Genomic Cancer Testing Revenue Market Share by Application (2018-2023)
Table 24. Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Genomic Cancer Testing Revenue Market Share by Application (2024-2033)
Table 26. North America Genomic Cancer Testing Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Genomic Cancer Testing Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Genomic Cancer Testing Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Genomic Cancer Testing Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Genomic Cancer Testing Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Genomic Cancer Testing Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Genomic Cancer Testing Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Genomic Cancer Testing Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Genomic Cancer Testing Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Genomic Cancer Testing Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Genomic Cancer Testing Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Genomic Cancer Testing Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Table 39. Date of Key Players Enter into Genomic Cancer Testing Market
Table 40. Global Genomic Cancer Testing Key Players Headquarters and Area Served
Table 41. Genomic Cancer Testing Product Solution and Service
Table 42. Global Genomic Cancer Testing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Devyser Basic Information List
Table 45. Devyser Description and Business Overview
Table 46. Devyser Genomic Cancer Testing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Genomic Cancer Testing Business of Devyser (2018-2023)
Table 48. Devyser Recent Developments
Table 49. Agendia Basic Information List
Table 50. Agendia Description and Business Overview
Table 51. Agendia Genomic Cancer Testing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Genomic Cancer Testing Business of Agendia (2018-2023)
Table 53. Agendia Recent Developments
Table 54. Illumina Basic Information List
Table 55. Illumina Description and Business Overview
Table 56. Illumina Genomic Cancer Testing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Genomic Cancer Testing Business of Illumina (2018-2023)
Table 58. Illumina Recent Developments
Table 59. Personal Genome Diagnostics Basic Information List
Table 60. Personal Genome Diagnostics Description and Business Overview
Table 61. Personal Genome Diagnostics Genomic Cancer Testing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Genomic Cancer Testing Business of Personal Genome Diagnostics (2018-2023)
Table 63. Personal Genome Diagnostics Recent Developments
Table 64. Veracyte Basic Information List
Table 65. Veracyte Description and Business Overview
Table 66. Veracyte Genomic Cancer Testing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Genomic Cancer Testing Business of Veracyte (2018-2023)
Table 68. Veracyte Recent Developments
Table 69. Pacific Biosciences of California Basic Information List
Table 70. Pacific Biosciences of California Description and Business Overview
Table 71. Pacific Biosciences of California Genomic Cancer Testing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Genomic Cancer Testing Business of Pacific Biosciences of California (2018-2023)
Table 73. Pacific Biosciences of California Recent Developments
Table 74. Qiagen Basic Information List
Table 75. Qiagen Description and Business Overview
Table 76. Qiagen Genomic Cancer Testing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Genomic Cancer Testing Business of Qiagen (2018-2023)
Table 78. Qiagen Recent Developments
Table 79. Agilent Technologies Basic Information List
Table 80. Agilent Technologies Description and Business Overview
Table 81. Agilent Technologies Genomic Cancer Testing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Genomic Cancer Testing Business of Agilent Technologies (2018-2023)
Table 83. Agilent Technologies Recent Developments
Table 84. Natera Basic Information List
Table 85. Natera Description and Business Overview
Table 86. Natera Genomic Cancer Testing Products, Services and Solutions
Table 87. Revenue (US$ Million) in Genomic Cancer Testing Business of Natera (2018-2023)
Table 88. Natera Recent Developments
Table 89. Bio Rad Laboratories Basic Information List
Table 90. Bio Rad Laboratories Description and Business Overview
Table 91. Bio Rad Laboratories Genomic Cancer Testing Products, Services and Solutions
Table 92. Revenue (US$ Million) in Genomic Cancer Testing Business of Bio Rad Laboratories (2018-2023)
Table 93. Bio Rad Laboratories Recent Developments
Table 94. Myriad Genetics Basic Information List
Table 95. Myriad Genetics Description and Business Overview
Table 96. Myriad Genetics Genomic Cancer Testing Products, Services and Solutions
Table 97. Revenue (US$ Million) in Genomic Cancer Testing Business of Myriad Genetics (2018-2023)
Table 98. Myriad Genetics Recent Developments
Table 99. North America Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 100. North America Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 101. Europe Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 102. Europe Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 103. Asia-Pacific Genomic Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Asia-Pacific Genomic Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 105. Asia-Pacific Genomic Cancer Testing Market Size by Region (2024-2033) & (US$ Million)
Table 106. Asia-Pacific Genomic Cancer Testing Market Share by Region (2018-2023)
Table 107. Asia-Pacific Genomic Cancer Testing Market Share by Region (2024-2033)
Table 108. Latin America Genomic Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Latin America Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 110. Latin America Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 111. Middle East & Africa Genomic Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 112. Middle East & Africa Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 113. Middle East & Africa Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 114. Genomic Cancer Testing Market Trends
Table 115. Genomic Cancer Testing Market Drivers
Table 116. Genomic Cancer Testing Market Challenges
Table 117. Genomic Cancer Testing Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomic Cancer Testing Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Genomic Cancer Testing Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Genomic Cancer Testing Market Share by Regions: 2022 VS 2033
Figure 4. Global Genomic Cancer Testing Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Genomic Cancer Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Genomic Cancer Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Genomic Cancer Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Genomic Cancer Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Genomic Cancer Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Fluorescence In Situ Hybridization
Figure 11. Global Fluorescence In Situ Hybridization Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Polymerase Chain Reaction
Figure 13. Global Polymerase Chain Reaction Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Microarray Technology
Figure 15. Global Microarray Technology Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Serum Proteomics
Figure 17. Global Serum Proteomics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Nucleic Acid Sequencing
Figure 19. Global Nucleic Acid Sequencing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Genomic Cancer Testing Market Size Share by Type: 2022 & 2033
Figure 21. North America Genomic Cancer Testing Revenue Market Share by Type (2018-2033)
Figure 22. Europe Genomic Cancer Testing Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Genomic Cancer Testing Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Genomic Cancer Testing Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Genomic Cancer Testing Revenue Market Share by Type (2018-2033)
Figure 26. Hospitals Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Speciality Clinics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Research Institutes Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Diagnostics Laboratories Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 30. Biopharmaceutical Companies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 31. Global Genomic Cancer Testing Market Size Share by Application: 2022 & 2033
Figure 32. North America Genomic Cancer Testing Revenue Market Share by Application (2018-2033)
Figure 33. Europe Genomic Cancer Testing Revenue Market Share by Application (2018-2033)
Figure 34. Asia-Pacific Genomic Cancer Testing Revenue Market Share by Application (2018-2033)
Figure 35. Latin America Genomic Cancer Testing Revenue Market Share by Application (2018-2033)
Figure 36. Middle East and Africa Genomic Cancer Testing Revenue Market Share by Application (2018-2033)
Figure 37. Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 38. Global Top 5 and Top 10 Players Genomic Cancer Testing Market Share in 2022
Figure 39. North America Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 40. United States Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 41. Canada Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 42. Germany Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 43. France Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 44. U.K. Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 45. Italy Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 46. Russia Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 47. Nordic Countries Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 48. Asia-Pacific Genomic Cancer Testing Market Share by Region (2018-2033)
Figure 49. China Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 50. Japan Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 51. South Korea Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 53. India Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 54. Australia Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 55. Latin America Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 56. Mexico Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 57. Brazil Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 58. Middle East & Africa Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 59. Turkey Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 60. Saudi Arabia Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 61. UAE Genomic Cancer Testing Market Size (2018-2033) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report